Clinical trials

The LFB group is conducting several clinical trials in order to register leading-edge biopharmaceuticals in Europe and the USA, in the fields of immunology, haemostasis and perinatal and intensive care.

There are four phase III clinical trials being developed at present. Three of LFB’s medicinal products are currently being registered in Europe or the USA.

For more information on ongoing clinical trials, you can go to the website.